An ultrasensitive and modular platform to detect Siglec ligands and control immune cell function

一种用于检测Siglec配体和控制免疫细胞功能的超灵敏模块化平台

阅读:12
作者:Zeinab Jame-Chenarboo ,Edward N Schmidt ,Madeline Crichton ,Kei Takahashi-Yamashiro ,Guilherme M Lima ,Liany Luna-Dulcey ,Jaesoo Jung ,Sabine Ivison ,Chris D St Laurent ,Jhon R Enterina ,Sung-Yao Lin ,Susmita Sarkar ,Maju Joe ,Fahima Mozaneh ,Reni John ,Som G Nanjappa ,Stacy A Malaker ,Megan K Levings ,Jamey D Marth ,Ratmir Derda ,Matthew S Macauley

Abstract

Siglecs are immunomodulatory receptors that regulate immune cell function. A fundamental challenge in studying Siglec-ligand interactions is the low affinity of Siglecs for their ligands. Inspired by how nature uses multivalency, we developed Siglec-liposomes as a highly multivalent and versatile platform for detecting Siglec glycan ligands in which recombinant Siglecs were conjugated to liposomes using the SpyCatcher-SpyTag system. Siglec-liposomes offer tunable multivalency and a modular assembly, enabling presentation of different Siglecs on the same liposome. Using Siglec-liposomes, we profiled Siglec ligands on human leukocytes, revealing distinct patterns of Siglec ligands. Moreover, Siglec-liposomes are in vivo compatible, where we demonstrated that Siglec-7-liposomes bind to the brain vasculature in a mucin domain-dependent manner. Given the abundance of Siglec ligands on T cells, we investigated whether Siglec-liposomes modulate T cell function and find that Siglec-7-liposomes increase T cell proliferation in an ST3Gal1-dependent and CD43-independent manner. Together, Siglec-liposomes are a versatile and sensitive tool for detecting Siglec ligands and immunomodulation.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。